Does Aetna Cover Weight Loss Treatment in Maine? A 2026 Guide

Last updated: July 20, 2026

If you are an Aetna member in Maine wondering whether your plan may cover weight loss treatment. Including GLP-1 medications like Wegovy or Zepbound. This guide explains what Aetna typically offers, how CVS/Caremark (Aetna’s pharmacy benefit manager) structures its weight loss formulary, and what Maine law does and does not require insurers to cover.

Coverage varies widely by plan. Always verify your specific benefits before booking an appointment or filling a prescription.

Klarity Health connects Maine residents with licensed weight loss providers for telehealth consultations. Our network of 2,000+ providers can evaluate your eligibility for GLP-1 medications and work with your Aetna plan on prior authorizations.

See If You May Qualify for Weight Loss Treatment →

Does Maine Law Require Aetna to Cover Weight Loss Treatment?

Maine’s primary insurance parity law. Me. Rev. Stat. Ann. tit. 24-A, § 2749-A. Requires commercial fully-insured plans to cover mental health and substance use disorder (MH/SUD) conditions at parity with medical-surgical benefits. Weight loss and obesity treatment are not classified as MH/SUD conditions under § 2749-A, so this statute does not require Aetna to cover weight loss medications.

Coverage for weight loss treatment in Maine is governed instead by:

• Federal ACA preventive care mandate: Plans must cover BMI screening and intensive behavioral counseling for obesity (USPSTF Grade B) at no cost-sharing. This covers counseling, not medications.
• Plan design and employer contract: Whether prescription weight loss medications are covered, and at what cost-sharing level, depends on your specific Aetna plan.
• ACA Essential Health Benefits (EHB): EHB do not mandate coverage of weight loss drugs for marketplace plans in Maine.

If your employer offers a self-funded ERISA plan through Aetna, the plan is governed by federal ERISA rules, not Maine insurance law. Self-funded plans set their own pharmacy benefit terms.

Maine Electronic Prescribing Requirements for Weight Loss Medications

Maine requires electronic prescribing (EPCS) for all controlled substances in Schedules II through V under Me. Rev. Stat. Ann. tit. 32, § 13796 et seq. Whether this applies to a specific weight loss medication depends on its federal controlled substance schedule:

Because GLP-1 medications (Wegovy, Zepbound, Saxenda) and Contrave are non-scheduled, Maine’s EPCS requirement does not apply to them. Phentermine and Qsymia are Schedule IV controlled substances. Prescribers in Maine must use an electronic prescribing system that meets DEA 21 CFR Part 1311 requirements to issue these prescriptions.

Qsymia also requires enrollment in the Qsymia REMS program due to teratogenicity risk, regardless of EPCS status.

CVS/Caremark Weight Loss Formulary for Aetna Members (2026)

Aetna uses CVS/Caremark as its pharmacy benefit manager. The CVS/Caremark weight loss formulary structures coverage for obesity medications as follows. Note that specific tier placement and prior authorization (PA) criteria may vary by your Aetna plan:

Important: Zepbound Reinstatement on CVS/Caremark (October 1, 2026)

CVS/Caremark removed Zepbound (tirzepatide) from its commercial formulary effective July 1, 2025, favoring Wegovy (semaglutide) as the preferred GLP-1 for weight management. However, CVS/Caremark reinstated Zepbound on its commercial formulary effective October 1, 2026. Aetna members with CVS/Caremark pharmacy benefits may now be eligible for Zepbound coverage. Subject to prior authorization and plan-specific BMI criteria. Starting on that date.

This is a key differentiator compared to Cigna members, whose pharmacy benefits are managed by Express Scripts (ESI). ESI never removed Zepbound from its formulary. Cigna/ESI members have had continuous Zepbound access at Tier 3. 4. Aetna members who were switched from Zepbound to Wegovy during the CVS/Caremark removal period may wish to discuss reinitiating Zepbound with their provider after October 1, 2026.

Aetna Prior Authorization Requirements for Weight Loss Medications

GLP-1 medications for weight loss typically require prior authorization (PA) through Aetna/CVS/Caremark. Common PA criteria may include:

• BMI threshold: BMI ≥30 kg/m² (obesity), or BMI ≥27 kg/m² with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease)
• Diagnosis documentation: Documented obesity or overweight diagnosis from a licensed provider
• Previous treatment attempts: Some plans require documented trial of behavioral/dietary intervention before approving pharmacotherapy
• Concurrent behavioral counseling: Plans may require enrollment in a weight management program alongside medication
• Prescriber specialty: Some plans limit prescribing to specific specialties (primary care, endocrinology, obesity medicine); telehealth prescribers may qualify depending on plan terms

PA decisions under Aetna’s standard process are typically rendered within 15 calendar days for non-urgent requests. Urgent PA requests (where a delay would seriously jeopardize health) must be decided within 72 hours.

Step Therapy and Formulary Exceptions

Aetna and CVS/Caremark may apply step therapy protocols requiring a trial of a lower-tier or preferred weight loss medication before approving a non-preferred agent. Maine does not have a specific step therapy exception statute for weight loss medications (unlike some other states). However, members may:

• Request a formulary exception if the preferred medication is contraindicated or clinically inappropriate
• Request a peer-to-peer review between the treating provider and Aetna’s medical director
• File a formal internal appeal if the PA request is denied (see the appeals section below)

ACA Preventive Coverage: Obesity Screening and Counseling

Under the Affordable Care Act, all non-grandfathered commercial health plans. Including Aetna plans in Maine. Must cover the following at no cost-sharing when delivered by an in-network provider:

• BMI screening and counseling: USPSTF Grade B recommendation. Covered for adults at no cost-sharing regardless of BMI result.
• Intensive behavioral counseling for obesity: For adults with BMI ≥30, plans must cover intensive multicomponent behavioral counseling (typically 22+ sessions in the first year) at no cost-sharing.

These preventive benefits cover counseling and behavioral interventions, not prescription medications. Medication coverage depends on your Aetna plan’s pharmacy benefit design.

How to Verify Your Aetna Weight Loss Coverage in Maine

Before starting weight loss treatment, take these steps to confirm your benefits:

1. Call Aetna Member Services: 1-800-872-3862 (number on the back of your insurance card). Ask specifically: “Does my plan cover weight loss medications such as Wegovy or Zepbound? What are the prior authorization requirements?”
2. Call CVS/Caremark: 1-800-552-8159. Ask about the tier placement, PA criteria, and estimated cost-sharing for the specific medication your provider is considering.
3. Use Aetna’s Member Portal: Log in at aetna.com to view your pharmacy benefits summary, formulary, and cost estimator tool.
4. Ask your provider to submit a PA request: Your Klarity provider can submit a prior authorization request on your behalf and provide the supporting clinical documentation.
5. File a grievance if denied: If your PA request is denied, you have the right to appeal (see below).

How to Appeal a Weight Loss Coverage Denial from Aetna in Maine

If Aetna denies your prior authorization request for a weight loss medication, you have several options:

1. Request the denial explanation in writing. Aetna must provide a written explanation of the specific clinical and contractual basis for the denial.
2. Peer-to-peer review. Your provider can request a peer-to-peer discussion with Aetna’s medical reviewer to present clinical evidence supporting the requested treatment.
3. Formal internal appeal. Submit a written appeal to Aetna with supporting documentation (medical records, provider letter, clinical guidelines). Aetna must respond within 30 days for standard non-urgent appeals, or 72 hours for urgent/expedited appeals.
4. External Independent Medical Review (IMR). If Aetna upholds the denial, you may request an external review by an independent review organization certified by the Maine Bureau of Insurance. Contact the Maine Bureau of Insurance at 1-800-300-5000 to initiate an external review request.
5. File a complaint with Maine Bureau of Insurance. If you believe Aetna has improperly denied coverage, you may file a formal complaint with the Maine Bureau of Insurance: 1-800-300-5000 or online at maine.gov/pfr/insurance.

Note: Maine § 2749-A parity rights apply to mental health and substance use disorder claims. They do not apply to weight loss coverage disputes. Weight loss appeals proceed under general insurance contract law and ACA appeal rights.

Klarity Health: Telehealth Weight Loss Treatment in Maine

Klarity Health works with Aetna members across Maine who are seeking evaluation for weight loss treatment. Our network of 2,000+ licensed providers offers telehealth consultations that may fit within your Aetna plan’s covered telehealth benefits.

What Klarity providers can do for Aetna members in Maine:

• Conduct a comprehensive weight management evaluation including BMI assessment and comorbidity review
• Determine eligibility for GLP-1 medications (Wegovy, Zepbound) or other FDA-approved weight loss pharmacotherapy
• Submit prior authorization requests to Aetna/CVS/Caremark with supporting clinical documentation
• Provide ongoing telehealth follow-up to monitor treatment response and adjust medications as needed
• Issue electronic prescriptions compliant with Maine EPCS requirements (required for phentermine, Qsymia)

Check If You May Qualify for Weight Loss Treatment →

Frequently Asked Questions

Does Aetna cover Wegovy in Maine?

Wegovy (semaglutide 2.4 mg) may be covered under Aetna plans in Maine that include pharmacy benefits for weight loss medications. Coverage typically requires prior authorization with documented BMI ≥30 or ≥27 with a qualifying comorbidity. Coverage varies by plan. Verify with Aetna at 1-800-872-3862.

Does Aetna cover Zepbound in Maine in 2026?

CVS/Caremark removed Zepbound from its commercial formulary on July 1, 2025, but reinstated it effective October 1, 2026. Aetna members with CVS/Caremark pharmacy benefits may be eligible for Zepbound coverage starting October 1, 2026, subject to prior authorization and plan-specific criteria. Contact CVS/Caremark at 1-800-552-8159 to confirm your plan’s coverage.

Does Maine law require Aetna to cover weight loss medications?

No. Maine’s mental health parity law (§ 2749-A) applies specifically to mental health and substance use disorder conditions. There is no Maine state law requiring commercial insurers to cover weight loss medications. Coverage depends on your plan’s pharmacy benefit design and federal ACA requirements.

Do I need a prescription for weight loss medications in Maine?

Yes. All FDA-approved weight loss prescription medications require a valid prescription from a licensed provider. GLP-1 medications such as Wegovy and Zepbound do not require an EPCS (electronic prescription for controlled substances) because they are non-scheduled. Phentermine and Qsymia are Schedule IV controlled substances and require EPCS in Maine.

Can I get weight loss treatment through telehealth with Aetna in Maine?

Many Aetna plans cover telehealth services for medical consultations, including obesity and weight management evaluations. Telehealth coverage specifics depend on your plan. Klarity Health providers offer telehealth weight loss consultations. Contact Aetna at 1-800-872-3862 to confirm your telehealth benefits before scheduling.

What if Aetna denies my GLP-1 prior authorization request?

You have the right to appeal. Request a peer-to-peer review between your provider and Aetna’s medical reviewer, then file a formal internal appeal with supporting clinical documentation. If Aetna upholds the denial, you may request an external independent medical review through the Maine Bureau of Insurance at 1-800-300-5000.

Key Contacts

• Aetna Member Services: 1-800-872-3862
• CVS/Caremark (Aetna PBM): 1-800-552-8159
• Maine Bureau of Insurance: 1-800-300-5000
• Maine DHHS: 1-800-977-6740
• DOL EBSA (ERISA plans): 1-866-444-3272
• CMS Medicare/Medicaid: 1-800-633-4227

Coverage information is based on publicly available Aetna and CVS/Caremark formulary data as of 2026. Actual coverage depends on your specific plan. This content is for informational purposes only and does not constitute insurance advice. Verify your benefits before booking an appointment or filling a prescription. Klarity Health is not affiliated with Aetna or CVS/Caremark.